FL
RPRX icon

Fort LP’s Royalty Pharma RPRX Stock Holding History

Fort LP’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,641
Closed -$239K – 153
2023
Q1 		$239K Sell
6,641
-891
-12% -$33K 0.62% 112
2022
Q4 		$298K Buy
7,532
+1,009
+15% +$42.1K 0.45% 137
2022
Q3 		$262K Sell
6,523
-390
-6% -$16.7K 0.33% 168
2022
Q2 		$291K Buy
+6,913
New +$283K 0.2% 209

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fort LP's RPRX Position: Q2 2023 in Review

Fort LP sold out of Royalty Pharma (RPRX) in Q2 2023, closing a stake of 6,641 shares — an estimated $239K sold.

Fort LP first reported a position in RPRX in Q2 2022 and held it in 4 quarters. The position peaked at $298K in Q4 2022. 325 funds tracked by Wall St. Rank hold RPRX as of Q2 2023.

  • Fort LP reported no remaining Royalty Pharma position as of Q2 2023 after selling out during the quarter.
  • Fort LP sold 6,641 Royalty Pharma shares in Q2 2023, an estimated $239K.
  • Fort LP first reported a position in Royalty Pharma in Q2 2022 and held it in 4 quarters.
  • Fort LP's Royalty Pharma position peaked at $298K in Q4 2022.
  • 325 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2023.

Based on Fort LP's 13F filing for Q2 2023, filed 11 Aug 2023.